Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma

Leuk Lymphoma. 2014 Mar;55(3):702-5. doi: 10.3109/10428194.2013.810736. Epub 2013 Jul 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Biopsy
  • Gastritis / diagnosis
  • Gastritis / etiology*
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / complications*
  • Lymphoma, B-Cell, Marginal Zone / drug therapy
  • Male
  • Middle Aged
  • Rituximab
  • Stomach Neoplasms / complications*
  • Stomach Neoplasms / drug therapy
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab